Dale G. Ando
2013
In 2013, Dale G. Ando earned a total compensation of $1.3M as Vice President, Therapeutic Development and Chief Medical Officer at Sangamo Biosciences, a 28% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $186,813 |
|---|---|
| Option Awards | $393,548 |
| Salary | $437,500 |
| Stock Awards | $278,760 |
| Total | $1,296,621 |
Ando received $437.5K in salary, accounting for 34% of the total pay in 2013.
Ando also received $186.8K in non-equity incentive plan, $393.5K in option awards and $278.8K in stock awards.
Rankings
In 2013, Dale G. Ando's compensation ranked 5,515th out of 12,286 executives tracked by ExecPay. In other words, Ando earned more than 55.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,515 out of 12,286 | 55th |
Division Manufacturing | 1,921 out of 4,612 | 58th |
Major group Chemicals And Allied Products | 555 out of 1,462 | 62nd |
Industry group Drugs | 396 out of 1,156 | 66th |
Industry Biological Products, Except Diagnostic Substances | 60 out of 196 | 69th |
Source: SEC filing on April 25, 2016.
Ando's colleagues
We found four more compensation records of executives who worked with Dale G. Ando at Sangamo Biosciences in 2013.